# Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

> **NCT07014007** · NA · RECRUITING · sponsor: **Pierre Fabre Dermo Cosmetique** · enrollment: 105 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DEVICE:** RV4421B- EV0407

## Key facts

- **NCT ID:** NCT07014007
- **Lead sponsor:** Pierre Fabre Dermo Cosmetique
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07014007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07014007, "Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07014007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*